Stay updated on Pembrolizumab for Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The updated page shows minor layout/formatting adjustments to the Study Details page without changing core trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:07:48.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.
    Difference
    2%
    Check dated 2025-10-06T05:38:16.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.
    Difference
    0.1%
    Check dated 2025-09-29T03:07:28.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element. No other substantive changes detected.
    Difference
    0.1%
    Check dated 2025-09-14T19:23:08.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T16:25:51.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new drug names like enzalutamide and pembrolizumab, while removing several detailed medical terms and previous location references.
    Difference
    2%
    Check dated 2025-08-31T12:04:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.